Poai, a biotechnology company specialized in cancer research driven by artificial intelligence, has announced a distinctive digital assets of $ 344.4 million centered around the distinctive symbol of Atehir, which represents for the first time a company listed on the Nasdaq Stock Exchange and is actively managed by the decentralized physical immunization network (DEBIN).
The capital strategy was developed under the guidance of DNAEndistive Devision and BTIG, which was the applicant, which was the applicant, was revealed on Monday. The DNA Fund said in a separate announcement that it was organized as special places simultaneously in public stocks (pipelines), where cash investment and encryption pipes that include eye contributions were combined with ATH tokens.
The structure allows the Devin Tokened infrastructure as the asset of the public budget, as it provides a mixed financing model linking traditional stock markets with decentralized computing networks. The ATH Ministry will be linked directly to the infrastructure to process the official treatment graphics of Atehir.
Aethir is a decentralized cloud network That provides GPU infrastructure for computing applications and high -performance games. The network uses Blockchain technology to coordinate and distribute access to material account resources, and place it as a major participant in the DePin market.
The original network is traded, ATH, currently with less than $ 0.06 with a market capital of about $ 2.3 billion, according to CoinMarketCap. Trading volume increased over 24 hours by more than 330 %, most likely to announce the predictive tumor cabinet.
Related to: Vc Roundup: Investors continue to return to DePin, Web3 Gaming, Layer-1 RWAS
Blockchain pivot stockpiles of tumors
The transmission of softening tumors to decentralized infrastructure has sparked early attention from investors, as the shares rose more than 70 % on Monday after announcing the digital asset cabinet. The gathering pushed the arrow to its highest level since March.
Before announcing, the auctioned oncology has spent the past two years trading the Pence Cup with limited revenues and the date of quarterly losses. The company has reported only $ 2,682 in revenues The second quarter From 2025 and 110,310 dollars in The first quarterIn addition to the net losses that exceed $ 2 million in each period.
In the last quarter, predictive oncology raised about $ 586,000 through a market supply facility to help finance operations.
In March, the company sold the Skyline Medical section, which manufactured a machine to manage automatic fluid waste used in medical centers, as part of a broader strategy to reduce expenses and re -focus on AI’s drug discovery.
The new oncology strategy is placed on an increasing group of CAP and small MicroCAP companies that are heading towards the decorative assets treasury. In July, the former biotechnology company 180 Life Sciences Named as Ethzilla And declared plans to accumulate ether (Eth) As the origin of the Ministry of Treasury.
Other companies circulated to the public, including Mail City Vintchens (MCVT), Nature Miracle (NMHI), Upexi (Upxi), Helius Medical Technologies (HSDT) and Avax oneWhich were previously working as AGRIFORCE cultivation systems, similar moves to integrate encryption assets into their public budgets.
Analysts at Standard Chartrad I have warned that digital treasury companies may have pressure to evaluate as the values of net assets of the market (MNAVS), which compare the value of the company’s institution to encryption property, continue to decline.
“We see the market saturation is the main engine for the last MNAV pressure,” said Standard Charterd, referring to the rapid increase in companies that adopt the Ministry of Digital Treasury strategies this year.
Related to: After a $ 400 million pride, the re -purchase ETH Treasuer Eyes Stock, amid fears related to the increase
